Momenta, Sandoz Sue Teva Over Lovenox Generic

Law360, New York (December 2, 2010, 6:29 PM EST) -- Momenta Pharmaceuticals Inc. and Sandoz Inc. have slapped Teva Pharmaceutical Industries Ltd. with a patent infringement suit in an effort to block Teva from producing a competing generic version of Sanofi-Aventis SA's anti-coagulant Lovenox.

In a complaint filed Thursday in the U.S. District Court for the District of Massachusetts, Momenta and Sandoz assert that Teva's plans to market a generic enoxaparin drug product in the U.S. infringes two of Momenta's patents.

The patents are U.S. Patent Number 7,575,886, titled “Analysis of sulfated polysaccharides,” which generally relates...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.